PNNL

Abstract

Breaking down the silos between disciplines to accelerate the pace of cancer research is a key paradigm for the Cancer Moonshot. Molecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. Proteogenomics represents a fusion of those two fields, leveraging the strengths of each to provide a more integrated vision of the flow of information from DNA to RNA to protein and eventually function. Proteogenomic studies have been incorporated into multiple activities associated with the cancer moonshot, demonstrating substantial added value. Innovative study designs integrating genomic, transcriptomic and proteomic data, particularly those that use clinically relevant samples and engage clinical trials, are poised to provide new insights regarding cancer risk, progression, and response to therapy,